Guangzhou Baiyunshan Pharmaceutical Holdings Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Hong Li
Chief executive officer
CN¥1.7m
Total compensation
| CEO salary percentage | 26.5% |
| CEO tenure | 5.9yrs |
| CEO ownership | n/a |
| Management average tenure | 5.3yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | CN¥4b |
| Dec 31 2022 | n/a | n/a | CN¥4b |
| Sep 30 2022 | n/a | n/a | CN¥4b |
| Jun 30 2022 | n/a | n/a | CN¥4b |
| Mar 31 2022 | n/a | n/a | CN¥4b |
| Dec 31 2021 | CN¥2m | CN¥456k | CN¥4b |
| Sep 30 2021 | n/a | n/a | CN¥4b |
| Jun 30 2021 | n/a | n/a | CN¥4b |
| Mar 31 2021 | n/a | n/a | CN¥3b |
| Dec 31 2020 | CN¥1m | CN¥442k | CN¥3b |
| Sep 30 2020 | n/a | n/a | CN¥3b |
| Jun 30 2020 | n/a | n/a | CN¥2b |
| Mar 31 2020 | n/a | n/a | CN¥3b |
| Dec 31 2019 | CN¥1m | CN¥428k | CN¥3b |
| Sep 30 2019 | n/a | n/a | CN¥3b |
| Jun 30 2019 | n/a | n/a | CN¥3b |
| Mar 31 2019 | n/a | n/a | CN¥4b |
| Dec 31 2018 | CN¥1m | CN¥382k | CN¥3b |
Compensation vs Market: Hong's total compensation ($USD243.37K) is below average for companies of similar size in the US market ($USD7.79M).
Compensation vs Earnings: Hong's compensation has been consistent with company performance over the past year.
CEO
Hong Li (55 yo)
5.9yrs
Tenure
CN¥1,719,019
Compensation
Mr. Hong Li has been General Manager at Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited since June 23, 2017 and serves as its Executive Director since June 22, 2018. Mr. Li started his career...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 12.9yrs | no data | no data | |
| GM & Executive Director | 5.9yrs | CN¥1.72m | no data | |
| Vice Chairman | 10.7yrs | no data | no data | |
| Vice Chairman | 3.3yrs | no data | no data | |
| Deputy GM & Executive Director | 8.3yrs | CN¥1.29m | no data | |
| Executive Director | no data | no data | no data | |
| Deputy GM & Executive Director | 7.3yrs | CN¥1.06m | no data | |
| Deputy GM & Director of Business Administration Department | 3.8yrs | CN¥1.35m | no data | |
| Secretary | 4.8yrs | CN¥1.23m | no data |
5.3yrs
Average Tenure
55yo
Average Age
Experienced Management: GZPH.F's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 12.9yrs | no data | no data | |
| GM & Executive Director | 4.9yrs | CN¥1.72m | no data | |
| Vice Chairman | 10.7yrs | no data | no data | |
| Vice Chairman | 3.3yrs | no data | no data | |
| Deputy GM & Executive Director | 12.9yrs | CN¥1.29m | no data | |
| Executive Director | 9.3yrs | no data | no data | |
| Deputy GM & Executive Director | 3.9yrs | CN¥1.06m | no data | |
| Independent Non-Executive Director | no data | CN¥100.00k | no data | |
| Independent Non-Executive Director | 5.9yrs | CN¥100.00k | no data | |
| Chairman of the Supervisory Board | 3.7yrs | no data | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥100.00k | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥100.00k | no data |
4.9yrs
Average Tenure
56yo
Average Age
Experienced Board: GZPH.F's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/26 22:55 |
| End of Day Share Price | 2023/02/27 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is covered by 29 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhi Xue Diao | Avic Securities Co., Ltd |
| null null | BOCI Research Ltd. |
| Feng Qiang Sun | BOCOM International Securities Limited |